tiprankstipranks
Trending News
More News >
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market

Compare Arcturus Therapeutics (ARCT) vs. Competitors

Compare
2,128 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Arcturus Therapeutics
$6.77
$192.36M
-2.75
-64.27%
6 Buy
3 Hold
0 Sell
Moderate Buy
Rigel
$44.50
$807.73M
7.22
173.85%
3 Buy
1 Hold
0 Sell
Strong Buy
Arvinas Holding Company
$12.18
$782.25M
-15.17
-38.55%
6 Buy
3 Hold
1 Sell
Moderate Buy
Compass Therapeutics
$5.17
$919.55M
-11.30
177.96%
8 Buy
0 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$25.57
$2.01B
-14.11
344.70%
11 Buy
0 Hold
0 Sell
Strong Buy
Erasca
$5.81
$1.65B
-12.89
111.27%
5 Buy
1 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARCT
Arcturus Therapeutics
6.77
-10.54
-60.89%
RIGL
Rigel
44.50
27.39
160.08%
ARVN
Arvinas Holding Company
12.18
-5.83
-32.37%
CMPX
Compass Therapeutics
5.17
3.22
165.13%
OLMA
Olema Pharmaceuticals
25.57
20.73
428.31%
ERAS
Erasca
5.81
3.66
170.23%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts